Almost 60 percent of adult emergency department visits are by patients with at least one chronic condition associated with severe COVID-19, according to a study published online Sept. 1 in the National Health Statistics ...
Sep 2, 2022
0
22
The prevalence of heart failure in the United States is a growing concern. A new study led by a Yale physician analyzes the variations in how often heart failure occurs in patients with risk factors such as hypertension, ...
Nov 3, 2020
0
25
An interdisciplinary team of Indiana University scientists studying Medicare data have found an association between health care industry payments to medical providers for non-research expenses and what these providers charge ...
Sep 20, 2019
1
93
About 3 million Americans live with cardiovascular implantable electronic devices—commonly known as pacemakers. These small electronic devices implanted in the chest or abdomen are typically used to treat slow or irregular ...
May 23, 2023
0
19
In today's fast-paced digital society, virtual doctor visits are on the rise and offer patients a more convenient way to receive medical care from anywhere. If you can't leave work or don't have childcare, for example, online ...
Mar 14, 2019
0
3
(HealthDay)—For veterans enrolled in the U.S. Department of Veterans Affairs (VA) and Medicare Part D, receipt of opioids from both VA and Part D is associated with an increased likelihood of death from prescription opioid ...
Mar 12, 2019
0
3
'Tis the season to pick your healthcare plan for the upcoming year.
Nov 17, 2022
0
2
Continuous glucose monitoring (CGM) is associated with improved health outcomes for patients with diabetes. Primary care practices, however, have been slow to adopt the technology. Researchers used a web-based survey to assess ...
Nov 29, 2022
0
2
(HealthDay)—Changes have been proposed to the Physician Fee Schedule to transform how Medicare pays for primary care, focusing on improvements in pay for care coordination and planning, according to a new payment rule published ...
Jul 16, 2016
0
7
Medicare could waste up to $605 million per year on the controversial Alzheimer's drug aducanumab if it is eventually approved for widespread use because it is supplied in vials containing fixed doses that may not be appropriate ...
Jun 27, 2022
1
13
